Literature DB >> 2891613

Taq I-generated HLA-DQ alpha polymorphism in Japanese patients with narcolepsy.

K Matsuki1, H Maeda, T Juji, H Inoko, A Ando, K Tsuji, Y Honda.   

Abstract

Taq I-generated HLA-DQ alpha restriction fragment length polymorphism was examined in Japanese patients with narcolepsy. All patients were DR2 positive and shared a 6.0 kb fragment, although this fragment was found only in 54% of the healthy DR2-positive Japanese. This finding added the DQ alpha gene to the list of candidates for the possible narcolepsy-susceptibility gene. In contrast, there was no complete association between narcolepsy and DX alpha restriction fragment length polymorphism. These findings suggest that a narcolepsy-susceptibility gene is located closer to the DQ locus than to the DX locus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2891613     DOI: 10.1007/bf00351080

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  15 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones.

Authors:  S Rosenshine; I Cascino; A Zeevi; R J Duquesnoy; M Trucco
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  HLA-DQ beta chain DNA restriction fragments can differentiate between healthy and narcoleptic individuals with HLA-DR2.

Authors:  H Inoko; A Ando; K Tsuji; K Matsuki; T Juji; Y Honda
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  DR2-negative narcolepsy.

Authors:  A Andreas-Zietz; E Keller; S Scholz; E D Albert; B Roth; S Nevsimalova; K Sonka; P Docekal; E Ivaskova; H Schulz
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

5.  Diagnostic criteria for narcolepsy and HLA-DR2 frequencies.

Authors:  K Matsuki; Y Honda; T Juji
Journal:  Tissue Antigens       Date:  1987-10

6.  HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive.

Authors:  T Juji; M Satake; Y Honda; Y Doi
Journal:  Tissue Antigens       Date:  1984-11

7.  Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types.

Authors:  R S Spielman; J Lee; W F Bodmer; J G Bodmer; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.

Authors:  K Matsuki; T Juji; K Tokunaga; T Naohara; M Satake; Y Honda
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence.

Authors:  G Poirier; J Montplaisir; F Décary; D Momège; A Lebrun
Journal:  Sleep       Date:  1986       Impact factor: 5.849

10.  HLA and narcolepsy in a German population.

Authors:  G Mueller-Eckhardt; K Meier-Ewert; D J Schendel; F B Reinecker; G Multhoff; C Mueller-Eckhardt
Journal:  Tissue Antigens       Date:  1986-09
View more
  4 in total

1.  The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.

Authors:  O Olerup; M Schaffer; J Hillert; C Sachs
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  HLA typing of Takayasu arteritis in Korea.

Authors:  M H Park; Y B Park
Journal:  Heart Vessels Suppl       Date:  1992

3.  HLA antigens in Japanese patients with myasthenia gravis.

Authors:  K Matsuki; T Juji; K Tokunaga; M Takamizawa; H Maeda; M Soda; Y Nomura; M Segawa
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

4.  DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis.

Authors:  D P Singal; B Reid; D Green; W G Bensen; M D'Souza
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.